Hydroxychloroquine and chloroquine retinopathy monitoring

Document first published:
Page updated:
Publication type:

On behalf of the national Regional Medicines Optimisation Committees (RMOCs) system, RMOC (South) has developed practical recommendations for safe ophthalmology monitoring of patients who are receiving long term hydroxychloroquine or chloroquine. The document outlines the risks of retinopathy and sets out a structured approach for health professionals to manage these risks.